Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Overactive Bladder (OAB)
.
Show all posts
Showing posts with label
Overactive Bladder (OAB)
.
Show all posts
Monday, February 8, 2021
FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB)
›
Urovant Sciences (Nasdaq: UROV) announced the U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA) for on...
›
Home
View web version
